Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06918639

Effectiveness of Pulpotomy in Symptomatic Permanent Teeth With Deep Caries Lesions

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Universidad Rey Juan Carlos · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Preservation of pulp tissue would allow it to continue to exert its defensive and physiological functions and more tooth tissue would be preserved, leading to less weakening of the tooth. In addition, root canal treatment is a more complex therapeutic process that requires the use of more instruments, more time and more visits. To date, most clinical studies that have evaluated the success of pulpotomy treatments have been conducted on teeth with immature apexes. More studies are needed to evaluate VPT success in the permanent dentition in the long term. In accordance with the above, the main objective of the study will be to determine the success of partial or total pulpotomy treatment in permanent teeth (\>18 adults) with a closed apex and symptoms compatible with irreversible pulpitis. At the same time, the association of factors related to the patient, the treated tooth and specific treatment factors with the success of pulpotomies will be determined. On the other hand, the patient, perception and satisfaction with the treatment received will be evaluated. All treatments (pulpotomies and restorations) will be carried out by the principal investigator. After recording the preoperative data, clinical and radiographic examination, a diagnosis will be made according to the classification of Wolters and collaborators , which will also guide us in the choice of pulp treatment: PP o CP Partial pulpotomy or complete pulpotomy. The maximum pulp haemostasis time will be 10 minutes. In both treatments, in the same appointment, the definitive restoration of the tooth will be carried out. The evaluations will be performed at one week, 3 , 6 and 12 months postoperatively. This evaluation shall be performed by an examiner who shall be different from the one performing the treatment. The main outcome of the present study will be the determination of the success of the pulpotomies. \- Is vital pulp therapy a highly successful treatment for teeth with irreversible pulpitis?. Outcome measure 1: Success rate of vital pulp therapy \- Do patients feel satisfied with this conservative pulp treatment? Outcome measure 2: Patient´s satisfaction with vital pulp therapy

Detailed description

Success shall be determined by the absence of signs and symptoms in addition to maintenance of pulp vitality. The presence of symptoms compatible with the presence of pulp pathology or the observation of pathological radiolucent lesions will indicate the need for root canal treatment and will be considered failure of vital pulp therapy treatment. After completion of the procedure, a patient survey will be given to the patient to record the patients, perception and satisfaction with the treatment received.

Conditions

Interventions

TypeNameDescription
PROCEDUREPulpotomyVPT: Partial pulpotomy: 2 mm of pulp tissue is removed with a high speed 014 diamond round bur different from the one used to remove carious tissue. In those cases in which access to the pulp tissue induces a painful sensation due to failure of the anaesthetic technique, intrapulpal anaesthesia shall be used, and this parameter shall be recorded.Cotton wool impregnated with 2.5% stabilised sodium hypochlorite shall be held over the pulp exposure to achieve haemostasis. If it is not possible to control bleeding, proceed to a complete pulpotomy procedure. If in this case it is impossible to achieve haemostasis, the possibility of performing a TPV is ruled out and the RCT is excluded from the study. Once haemostasis has been achieved, BiodentineXp is applied according to the manufacturer's instructions and a material thickness of 2-3 mm is ensured. Full pulpotomy: The same anterior procedure .Complete removal of the tissue from the pulp chamber. Maximum haemostasis time: 10 minutes

Timeline

Start date
2024-04-11
Primary completion
2026-01-01
Completion
2027-01-01
First posted
2025-04-09
Last updated
2025-04-09

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06918639. Inclusion in this directory is not an endorsement.